Companies / Geron
Geron
United States
Geron Corporation is a biopharmaceutical company that focuses on hematology, specifically on diseases such as lower-risk myelodysplastic syndromes and myelofibrosis.
Geron, based in United States, has 1 investor on file, among them NEA. Its site was last checked 20 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
In the news
2 headlines naming GeronEach headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.
More from NEA
562 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (31%), Enterprise Software (19%), AI & Machine Learning (18%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Geron and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when NEA adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/geron.com/investors
# also
GET /v1/companies/geron.com
GET /v1/companies/geron.com/news